Persistent URL of this record https://hdl.handle.net/1887/136271
Documents
-
- Download
- Title Pages_Contents
-
open access
-
- Download
- Chapter 3
-
open access
- Full text at publishers site
-
- Download
- Chapter 5
-
open access
- Full text at publishers site
-
- Download
- Summary in Dutch
-
open access
-
- Download
- Abbreviations_Publications_Curriculum Vitae
-
open access
-
- Download
- Propositions
-
open access
In Collections
This item can be found in the following collections:
Development of novel anti-cancer strategies utilizing the zebrafish xenograft model
In chapters 3 and 4, we explore novel PDT and PACT compounds, respectively, for treatment of conjunctival melanoma in zebrafish. We...Show moreIn this thesis, we will utilize embryonic zebrafish tumour models to understand the interaction between engrafted human cancer cells and macrophages from the host, test drug administration modalities and anti-cancer efficacies of newly-developed PDT and PACT compounds, and test a light-triggered liposomal system for targeted drug delivery specifically to cancer cells in vivo. In chapter 2, we investigate the role of macrophages in tumour-induced angiogenesis. We show that macrophage-dependent angiogenesis is driven by macrophage recruitment to lactic acid secreted by glycolytic B16 melanoma cells. Chemical inhibition of macrophages and glycolysis blocks the initiation of angiogenesis in these models, suggesting that macrophages attracted to glycolytic melanoma cells contribute to the tumour-induced angiogenesis process.
In chapters 3 and 4, we explore novel PDT and PACT compounds, respectively, for treatment of conjunctival melanoma in zebrafish. We inject conjunctival melanoma cells into the retro-orbital site to establish an orthotopic model and into the Duct of Cuvier to generate an ectopic model. Our results prove that zebrafish provides a fast vertebrate cancer model to test the optimal administration regimen of drugs, conditions of light irradiation, host toxicity and anti-cancer efficacy of PDT and PACT drugs against conjunctival melanoma.
In chapter 5, we focus on modifying liposomes to be light triggered in order to deliver drugs specifically to cancer cells. We inject MDA231 breast cancer cells into the Duct of Cuvier at 2 days post fertilization (dpf) to initiate metastasis to the CHT. We successfully demonstrate that light-triggered, cell-specific delivery of liposome-encapsulated doxorubicin reduces the xenograft cancer cell burden without enhanced cytotoxicity of the zebrafish embryos. In chapter 6, we summarize the novel anti-cancer strategies, which we have developed using zebrafish xenograft models. In the same chapter, we frame our findings in the current scientific landscape and discuss future perspectives.Show less
- All authors
- Chen, Q.
- Supervisor
- Snaar-Jagalska B.E., Bonnet S.A.
- Committee
- Wezel, G.P. van; Meijer, A.H.; Kros, A.; Dijke, P. ten; Jager, M.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Institute of Biology (IBL) , Faculty of Science , Leiden University
- Date
- 2020-09-01
- ISBN (print)
- 9789492597496